Revvity ($RVTY) Stock Forecast: Down 5.3% Today

What is Revvity?

Revvity Inc (NYSE: RVTY) is a life sciences and diagnostics company that recently reported strong Q4 2025 financial results, surpassing earnings and revenue forecasts. Despite this positive performance, the stock experienced a bearish movement today.

Why is Revvity going down?

RVTY stock is down 5.3% on Feb 3, 2026 20:56

• An analyst raised Revvity's price target to $124 from $120, reflecting a 15% premium over the current share price, but the stock saw a pre-market decline, possibly leading to profit-taking by investors.
• Despite positive momentum indicators and analyst upgrades, including from another firm, the market movement could be influenced by broader market trends or sector-specific challenges impacting investor sentiment.
• The strong Q4 results and optimistic fiscal 2026 outlook may have already been priced into the stock, leading to a sell-off after the earnings announcement as investors locked in gains.
• Overall, the bearish movement in Revvity's stock today could be a result of a combination of profit-taking, market dynamics, and potential overvaluation following the recent price target upgrades and positive analyst forecasts.

RVTY Price Chart

RVTY Technical Analysis

RVTY News

Revvity stock price target raised to $124 from $120 at TD Cowen

TD Cowen has increased its price target for Revvity Inc (NYSE:RVTY) to $124.00 from $120.00 while maintaining a Buy rating. This adjustment reflects a 15% premium over the current share price and follows upward revisions of earnings expectations by other analysts. The life sciences and diagnostics company recently surpassed EPS and revenue forecasts for Q4 2025, although its stock saw a pre-market decline.

https://www.investing.com/news/analyst-ratings/revvity-stock-price-target-raised-to-124-from-120-at-td-cowen-93CH-4482273

Revvity stock price target raised to $124 from $120 at TD Cowen

TD Cowen has increased its price target for Revvity Inc (NYSE:RVTY) from $120 to $124, while maintaining a Buy rating. This new target represents a 15% premium over the current share price, with five analysts recently revising earnings expectations upward. Despite strong Q4 2025 financial results, the stock saw a pre-market decline, and KeyBanc also reiterated an Overweight rating with a $125 price target.

https://m.investing.com/news/analyst-ratings/revvity-stock-price-target-raised-to-124-from-120-at-td-cowen-93CH-4482273?ampMode=1

Here's Why Revvity (RVTY) is a Strong Momentum Stock

Revvity (RVTY) is identified as a strong momentum stock based on the Zacks Style Scores system. The article highlights RVTY's Momentum Style Score of "A" and its upward share price trend, along with recent positive earnings estimate revisions, making it an attractive option for momentum investors. The Zacks Rank and Style Scores methodology are explained as tools for investors to identify stocks with high potential to outperform the market.

https://www.nasdaq.com/articles/heres-why-revvity-rvty-strong-momentum-stock

Revvity (RVTY) Receives Price Target Boost from Evercore ISI Gro

Evercore ISI Group has reaffirmed its "Outperform" rating for Revvity (RVTY) and increased its price target from $112 to $118, indicating a 5.36% rise and a positive outlook. This adjustment comes amidst several recent positive analyst ratings and target increases from other firms like Wells Fargo and Barclays. The average one-year price target from 16 analysts is $118.08, suggesting a 10.26% upside from the current price, with a consensus "Outperform" recommendation from 20 brokerage firms.

https://www.gurufocus.com/news/8577772/revvity-rvty-receives-price-target-boost-from-evercore-isi-group-rvty-stock-news

Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results

Revvity (NYSE: RVTY) reported better-than-expected Q4 2025 earnings and sales, with adjusted earnings of $1.70 per share and sales of $772.06 million, surpassing analyst consensus. The company also issued an optimistic fiscal 2026 outlook. Following these results, several analysts, including those from Jefferies, Barclays, Wells Fargo, and Evercore ISI Group, raised their price targets for Revvity stock.

https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50333238/revvity-analysts-boost-their-forecasts-following-better-than-expected-q4-results

Trending Today

Solana ($SOL) Crypto Forecast: Down 5.4% Today

Revvity ($RVTY) Stock Forecast: Down 5.3% Today

Akamai Technologies Inc. ($AKAM) Stock Forecast: Down 5.1% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Up 5.1% Today

NXP Semiconductors N.V. ($NXPI) Stock Forecast: Down 6.1% Today

FedEx Corporation ($FDX) Stock Forecast: Up 5.5% Today

Freeport-McMoRan Inc. ($FCX) Stock Forecast: Up 6.5% Today

Adobe Inc. ($ADBE) Stock Forecast: Down 7.2% Today

PPL Corporation ($PPL) Stock Forecast: Down 1.1% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 5.4% Today

Revvity Price History

22.00.2026 - RVTY Stock was up 5.3%

• Today's positive movement in Revvity can be linked to the optimistic investor sentiment driven by the company's robust financial performance and strategic partnerships.
• The partnership announcement with Eli Lilly to incorporate AI models into Revvity Signals platform likely bolstered investor trust in the company's future growth possibilities.
• The acquisition of a significant stake by Campbell & CO Investment Adviser LLC and Revvity's sanctioned share buyback program reflect confidence from institutional investors and the company itself.
• The recently finalized $650 million sale of Avantor's clinical services business to Revvity may have also played a part in the positive trend, highlighting Revvity's tactical expansion and potential for increased revenue.

03.01.2026 - RVTY Stock was down 5.3%

• An analyst raised Revvity's price target to $124 from $120, reflecting a 15% premium over the current share price, but the stock saw a pre-market decline, possibly leading to profit-taking by investors.
• Despite positive momentum indicators and analyst upgrades, including from another firm, the market movement could be influenced by broader market trends or sector-specific challenges impacting investor sentiment.
• The strong Q4 results and optimistic fiscal 2026 outlook may have already been priced into the stock, leading to a sell-off after the earnings announcement as investors locked in gains.
• Overall, the bearish movement in Revvity's stock today could be a result of a combination of profit-taking, market dynamics, and potential overvaluation following the recent price target upgrades and positive analyst forecasts.

05.00.2026 - RVTY Stock was up 1.8%

• The upward movement in RVTY's stock can be linked to the positive market sentiment surrounding its upcoming Q4 2025 earnings, with analysts forecasting an increase in adjusted EPS and a strong history of surprise earnings.
• The notable increase in stake of Allspring Global Investments Holdings LLC by 14,741.7% in Q3, coupled with the company's stock buyback initiative and quarterly dividend declaration, likely bolstered investor confidence and contributed to the positive trend.
• Moreover, the acquisition of RVTY shares by Diamond Hill Mid Cap Strategy in Q3, based on the company's undervaluation and enhanced product portfolio, may have further fueled optimism among traders, leading to the rise in the stock price.
• In summary, positive earnings outlook, institutional investments, and strategic acquisitions have propelled RVTY's stock on an upward trajectory, reflecting investor confidence in the company's growth potential.

30.06.2025 - RVTY Stock was down 5.2%

• Revvity exceeded expectations for Q2 earnings and revenue, indicating growth in the Diagnostics business and a rebound in Life Sciences sales, possibly boosting investor confidence.
• The revision of FY25 EPS guidance due to challenges related to China DRG policy may have caused investor concerns and influenced the stock's bearish trend.
• Despite consistently surpassing earnings estimates previously, uncertainties surrounding policy changes in key markets like China might have overshadowed the company's positive financial performance, contributing to the stock's decline.

13.00.2026 - RVTY Stock was up 5.3%

• Revvity's stock saw a strong bullish movement today, rising by 6.9% ahead of the U.S. stock market open.
• The positive market response could be attributed to the company's recent guidance hike and exceeding the top-end of its EPS and revenue guidance, indicating stronger-than-expected financial performance.
• Investors might be optimistic about Revvity's upcoming earnings report and the anticipated financial results, with revenue expectations for the fourth quarter and full year 2025 looking promising.
• The presentation suggesting that existing end market trends will continue into 2026 could have also contributed to the bullish sentiment surrounding Revvity's stock today.

13.00.2026 - RVTY Stock was up 7.7%

• Revvity stock surged by 6.9% in premarket trading, following a 5% jump after the company raised its full-year profit outlook. This positive guidance hike ahead of the earnings report seems to have instilled confidence in investors.
• The company exceeded the top-end of its EPS and revenue guidance, indicating robust financial performance. This unexpected positive news likely contributed to the bullish movement in the stock price.
• With Revvity expecting to surpass its Q4 guidance with 6% revenue growth and adjusted earnings per share above previous estimates, investors are optimistic about the company's future financial health.
• The upcoming earnings call on February 2, 2026, where Revvity will provide a detailed update on its financial performance, is anticipated to be a key event that investors are looking forward to, driving the bullish sentiment further.

06.00.2026 - RVTY Stock was up 5.4%

• The introduction of Signals Xynthetica, the AI-augmented design platform, is believed to have instilled optimism among investors, leading to a rise in RVTY stock.
• Analysts are expecting a positive Q4 2025 earnings statement, projecting an 8.5% increase in adjusted EPS, potentially enhancing investor trust in the company's future growth.
• The notable rise in investment from Allspring Global Investments Holdings LLC, along with Revvity's stock repurchase program and dividend declaration, signifies robust investor interest and backing for Revvity's upcoming performance.
• Although some caution exists due to high valuations and prior underperformance, the general market sentiment appears to have shifted positively towards Revvity, evident in the recent bullish activity.

23.06.2025 - RVTY Stock was up 7.1%

• Revvity (RVTY) is expected to beat earnings estimates for the second quarter, as analysts are optimistic about its key metrics and overall performance.
• The positive outlook and anticipation of a strong earnings report likely contributed to the bullish movement in Revvity's stock price today.
• Investors are showing confidence in Revvity's potential for growth and profitability, driving the stock higher in anticipation of positive news from the upcoming earnings release.

22.06.2025 - RVTY Stock was up 5.1%

• The bullish movement in RVTY's stock price could be attributed to the market's anticipation of a positive earnings report for the second quarter.
• Investors seem optimistic about RVTY's ability to surpass earnings estimates, leading to increased buying activity and driving the stock price higher.
• The positive outlook for RVTY reflects the market's confidence in the company's performance and growth prospects, positioning it as a favorable investment option in the tech sector.

10.05.2025 - RVTY Stock was up 4.1%

• RVTY stock experienced a strong bullish movement today, outperforming market expectations.
• The positive market sentiment could be attributed to the company's recent product launches and strategic partnerships, driving investor confidence in its growth potential.
• Investors are optimistic about RVTY's future earnings prospects, leading to increased buying interest and pushing the stock price higher.
• The bullish trend indicates a favorable outlook for RVTY, with potential for further upside as market conditions remain supportive.

03.01.2026 - RVTY Stock was up 1.5%

• Analysts from several firms, such as TD Cowen, Evercore ISI Group, Wells Fargo, and KeyBanc, have increased their price targets for Revvity stock, indicating a favorable outlook for the company.
• The company's impressive Q4 performance, surpassing adjusted earnings expectations and providing a positive fiscal 2026 outlook, has led to the heightened price targets and ratings.
• Revvity's board approving a $1.0 billion share buyback program has also influenced analysts' recommendations and contributed to the upward movement in the stock.
• The optimistic future outlook, strong financial results, and positive analyst assessments have collectively driven the bullish trend for Revvity (RVTY) stock.

14.00.2026 - RVTY Stock was up 5.1%

• Following the release of upbeat Q4 earnings forecasts, Revvity's stock experienced a notable surge, underlining robust revenue expansion.
• Market analysts have backed the stock with a "Buy" recommendation, setting an average price target of $120.24, which has heightened investor confidence in the company's trajectory.
• While concerns surrounding the stock's potential overvaluation based on the P/E ratio have surfaced, the positive anticipated financial performance and optimistic 2026 outlook have eclipsed these reservations, propelling the bullish market sentiment.
• The upcoming earnings call and the CEO's presentation at the J.P. Morgan Healthcare Conference are poised to offer additional insights into Revvity's financial standing and future growth prospects, potentially sustaining the positive momentum surrounding the stock.